For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Aggregate Analysis of Monoclonal Antibodies using bioZen SEC-3 Column
Monoclonal antibody (mAb) aggregates have significant implications in safety, immunogenicity, and efficacy for therapeutic drug development. Size exclusion chromatography (SEC) is one of the laboratory methods used to determine the extent of aggregation of a protein. This method demonstrates the separation of three mAbs trastuzumab, infliximab, and cetuximab with the use of the bioZen SEC-3 column.
Aggregate Analysis of Monoclonal Antibodies using bioZen SEC-3 Column
Monoclonal antibody (mAb) aggregates have significant implications in safety, immunogenicity, and efficacy for therapeutic drug development. Size exclusion chromatography (SEC) is one of the laboratory methods used to determine the extent of aggregation of a protein. This method demonstrates the separation of three mAbs trastuzumab, infliximab, and cetuximab with the use of the bioZen SEC-3 column.
Document Type:
Technical Notes
Techniques:
Brands:
Separation Modes:
Size Exclusion
Phases: